Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Bacteria as tumour-targeting vectors.

Pawelek JM, Low KB, Bermudes D.

Lancet Oncol. 2003 Sep;4(9):548-56. Review. Erratum in: Lancet Oncol. 2003 Nov;4(11):658.

PMID:
12965276
2.

Use of bacteria as anticancer agents.

Jain KK.

Expert Opin Biol Ther. 2001 Mar;1(2):291-300. Review.

PMID:
11727536
3.

Tumour targeting with systemically administered bacteria.

Morrissey D, O'Sullivan GC, Tangney M.

Curr Gene Ther. 2010 Feb;10(1):3-14. Review.

PMID:
20156191
4.

Bacterial targeted tumour therapy-dawn of a new era.

Wei MQ, Mengesha A, Good D, Anné J.

Cancer Lett. 2008 Jan 18;259(1):16-27. Review.

PMID:
18063294
5.

Tumor-specific gene delivery using genetically engineered bacteria.

Theys J, Barbé S, Landuyt W, Nuyts S, Van Mellaert L, Wouters B, Anné J, Lambin P.

Curr Gene Ther. 2003 Jun;3(3):207-21. Review.

PMID:
12762480
6.

Use of bacteria in anti-cancer therapies.

Ryan RM, Green J, Lewis CE.

Bioessays. 2006 Jan;28(1):84-94. Review.

PMID:
16369949
7.

Bacteria and bacterial toxins as therapeutic agents for solid tumors.

Michl P, Gress TM.

Curr Cancer Drug Targets. 2004 Dec;4(8):689-702. Review.

PMID:
15578923
8.

Viral vectors for gene-directed enzyme prodrug therapy.

Schepelmann S, Springer CJ.

Curr Gene Ther. 2006 Dec;6(6):647-70. Review.

PMID:
17168697
9.

Bacteria: prospective savior in battle against cancer.

Nair N, Kasai T, Seno M.

Anticancer Res. 2014 Nov;34(11):6289-96. Review.

PMID:
25368227
10.

Engineering the perfect (bacterial) cancer therapy.

Forbes NS.

Nat Rev Cancer. 2010 Nov;10(11):785-94. doi: 10.1038/nrc2934. Epub 2010 Oct 14. Review.

11.

Bacteria in cancer therapy: a novel experimental strategy.

Patyar S, Joshi R, Byrav DS, Prakash A, Medhi B, Das BK.

J Biomed Sci. 2010 Mar 23;17(1):21. doi: 10.1186/1423-0127-17-21. Review.

12.

The use of clostridial spores for cancer treatment.

Barbé S, Van Mellaert L, Anné J.

J Appl Microbiol. 2006 Sep;101(3):571-8. Review.

13.

Therapeutic options to target angiogenesis in human malignancies.

Herbst RS.

Expert Opin Emerg Drugs. 2006 Nov;11(4):635-50. Review.

PMID:
17064223
14.

Bacterial vectors and delivery systems in cancer therapy.

Gardlik R, Fruehauf JH.

IDrugs. 2010 Oct;13(10):701-6. Review.

PMID:
20878592
15.

Bacterial gene therapy strategies.

Vassaux G, Nitcheu J, Jezzard S, Lemoine NR.

J Pathol. 2006 Jan;208(2):290-8. Review.

PMID:
16362987
16.

Novel pharmacological agents in clinical development for solid tumours.

Dy GK, Haluska P, Adjei AA.

Expert Opin Investig Drugs. 2001 Dec;10(12):2059-88. Review.

PMID:
11772306
17.

Vascular disrupting agents: a new class of drug in cancer therapy.

Gaya AM, Rustin GJ.

Clin Oncol (R Coll Radiol). 2005 Jun;17(4):277-90. Review.

PMID:
15997924
18.

Gene therapy for cancer: dairy bacteria as delivery vectors.

Tangney M.

Discov Med. 2010 Sep;10(52):195-200. Review.

19.

Chemotherapeutic tumour targeting using clostridial spores.

Minton NP, Mauchline ML, Lemmon MJ, Brehm JK, Fox M, Michael NP, Giaccia A, Brown JM.

FEMS Microbiol Rev. 1995 Oct;17(3):357-64. Review.

PMID:
7576773
20.

Cancer chemotherapy using suicide genes.

Singhal S, Kaiser LR.

Surg Oncol Clin N Am. 1998 Jul;7(3):505-36. Review.

PMID:
9624215

Supplemental Content

Support Center